{"data":{"Year":[2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2016,2017,2018,2019,2020,2014,2015,2016,2017,2018,2019,2020],"SDG Series":["Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) [3.b.1]","Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) [3.b.1]","Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) [3.b.1]","Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) [3.b.1]","Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) [3.b.1]","Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) [3.b.1]","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) [3.b.1]","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) [3.b.1]","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) [3.b.1]","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) [3.b.1]","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) [3.b.1]","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) [3.b.1]","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) [3.b.1]"],"Value":[52,55,57,59,62,64,64,73,71,79,80,82,83,84,85,89,93,94,93,93,89,30,57,74,64,30,60,64,77,90,92,92,89]},"edges":[]}